Preferred Label : extensively drug-resistant tuberculosis;
MeSH definition : Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main
classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES;
THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.;
MeSH synonym : drug-resistant tuberculoses, extensively; drug-resistant tuberculoses, extremely; drug-resistant tuberculosis, extensively; extremely drug resistant tuberculosis; tuberculoses, extensively drug-resistant; tuberculoses, extremely drug-resistant; tuberculosis, extensively drug-resistant; tuberculosis, extremely drug resistant; xdr-tb; tuberculosis, extensively drug resistant; extremely drug-resistant tuberculosis; drug-resistant tuberculosis, extremely; extremely drug-resistant tuberculoses; tuberculosis, extremely drug-resistant; extensively drug-resistant tuberculoses; extensively drug resistant tuberculosis;
MeSH annotation : coordinate with specific type of tuberculosis specific antitubercular agents if
pertinent;
Origin ID : D054908;
UMLS CUI : C1827301;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main
classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES;
THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=483
http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20141218_tuberbacilresistdiagetprischarg.pdf
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=484
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=485
2014
false
false
false
France
French
public health guidelines
tuberculosis, multidrug-resistant
extensively drug-resistant tuberculosis
tuberculosis, multidrug-resistant
france
tuberculosis, multidrug-resistant
tuberculosis, multidrug-resistant
algorithms
tuberculosis, multidrug-resistant
tuberculosis, multidrug-resistant
antitubercular agents
adult
child
disease management
antibiotic therapy
---